Literature DB >> 25429794

Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.

Lorna Stemberger Maric1, Ivica Knezovic, Neven Papic, Branko Mise, Srdan Roglic, Leo Markovinovic, Goran Tesovic.   

Abstract

Kawasaki disease (KD) is an acute systemic vasculitis of childhood. Due to development of coronary artery aneurysms (CAA) it is considered the most common cause of acquired heart disease in children. The clinical and laboratory features of patients with complete and incomplete KD were compared in order to identify the possible predictors of CAA development. A cross-sectional study of children with KD treated at the University Hospital for Infectious Diseases, Zagreb, between January 2003 and December 2012 was conducted. A total of 111 KD patients were included; 70.3% patients had complete KD. Patients with complete KD had more frequently rash, changes on extremities and mucous membranes, as well as higher serum bilirubin, aminotransferases, gamma-glutamyl transferase and lactate dehydrogenase levels. Patients with incomplete KD had longer duration of fever before the diagnosis (8 vs. 7 days) and delayed IVIG treatment (day 8 vs. 7). CAA was detected in seven children (6.3%). Disease duration before hospitalization >6 days (OR 7.16, 95% CI 1.51-100.35), age <6 months (OR 25.86, 95% CI 1.68-398.35) and platelet count >771 after the 7th day of disease (OR 13.33, 95% CI 2.19-80.87) were independently associated with CAA development. The diagnosis and treatment in incomplete KD can be delayed due to the absence of major criteria. Age, duration of symptoms prior hospitalization and platelet count were identified as independent predictors of CAA development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25429794     DOI: 10.1007/s00296-014-3186-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Kawasaki disease: summary of the American Heart Association guidelines.

Authors:  Alexandra F Freeman; Stanford T Shulman
Journal:  Am Fam Physician       Date:  2006-10-01       Impact factor: 3.292

2.  Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.

Authors:  Sunil J Ghelani; Craig Sable; Bernhard L Wiedermann; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

3.  A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children.

Authors:  Jingjing Chen; Yali Liu; Wenhua Liu; Zubo Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

4.  Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.

Authors:  Amy Patel; Robert C Holman; Laura S Callinan; Nandini Sreenivasan; Lawrence B Schonberger; Thea K Fischer; Ermias D Belay
Journal:  Acta Paediatr       Date:  2013-01-21       Impact factor: 2.299

5.  Complete and incomplete Kawasaki disease: two sides of the same coin.

Authors:  Cedric Manlhiot; Erin Christie; Brian W McCrindle; Hans Rosenberg; Nita Chahal; Rae S M Yeung
Journal:  Eur J Pediatr       Date:  2011-12-03       Impact factor: 3.183

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

7.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

8.  Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease.

Authors:  A Ishiguro; T Ishikita; T Shimbo; K Matsubara; K Baba; Y Hayashi; S Naritaka; T Nakahata
Journal:  Thromb Haemost       Date:  1998-06       Impact factor: 5.249

9.  Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Authors:  Georgia Giannouli; Chryssa Tzoumaka-Bakoula; Ioannis Kopsidas; Paraskevi Papadogeorgou; George P Chrousos; Athanasios Michos
Journal:  Pediatr Cardiol       Date:  2013-03-06       Impact factor: 1.655

Review 10.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

View more
  7 in total

1.  Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.

Authors:  Maho Yamashita; Ryusuke Ae; Mayumi Yashiro; Yasuko Aoyama; Takashi Sano; Nobuko Makino; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2016-11-23       Impact factor: 1.655

2.  A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease?

Authors:  Pandiarajan Vignesh; Sagar Bhattad; Manphool Singhal; Surjit Singh
Journal:  Rheumatol Int       Date:  2016-05-06       Impact factor: 2.631

Review 3.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

4.  Challenges in early diagnosis of Kawasaki disease in the pediatric emergency department: differentiation from adenoviral and invasive pneumococcal disease.

Authors:  Lorna Stemberger Maric; Neven Papic; Mario Sestan; Ivica Knezovic; Goran Tesovic
Journal:  Wien Klin Wochenschr       Date:  2018-02-23       Impact factor: 1.704

5.  Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease

Authors:  Huixian Qiu; Chang Jia; Zhenquan Wang; Yuee He; Xing Rong; Rongzhou Wu; Maoping Chu; Hongying Shi
Journal:  Balkan Med J       Date:  2020-07-28       Impact factor: 2.021

6.  Incidence Rate and Epidemiological and Clinical Aspects of Kawasaki Disease in Children of Maghrebi Origin in the Province of Quebec, Canada, Compared to the Country of Origin.

Authors:  Arbia Abir Gorrab; Anne Fournier; Asma Abed Bouaziz; Linda Spigelblatt; Rosie Scuccimarri; Ali Mrabet; Nagib Dahdah
Journal:  Glob Pediatr Health       Date:  2016-02-16

Review 7.  Controversies in diagnosis and management of Kawasaki disease.

Authors:  Rakesh Kumar Pilania; Dharmagat Bhattarai; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2018-02-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.